Friday, July 30, 2010

SHAPE Board Meeting and Welcome Dinner – Presentation by Sponsor: Panasonic Healthcare

Saturday, July 31, 2010
6:30 am – 7:45 am

10:15 am – 12:00 pm
New Developments in Carotid Ultrasound IMT and Plaque Assessment
(Measuring Risk and Monitoring Progression/Regression) – Insights from ARIC, MESA, ARBITER-6, and HRP Studies

Howard Hodis, M.D.

The SHAPE II Guidelines – Opening Remarks by Morteza Naghavi, M.D.

The SHAPE II Guidelines – Moderator,P.K. Shah, M.D.

8:00 am – 10:00 am

Review the 1st SHAPE Guidelines – What’s New in CVD Risk assessment and screening since 2005?

Erling Falk, M.D.

J. David Spence, M.B.A., M.D.

Tasneem Naqvi, M.D.

Henrik, Sillesen, M.D., D.MSc.

Steven B. Feinstein, M.D.

12:15 am – 1:30 pm

New Developments in Coronary Calcium and CT Angiography
(Measuring Risk and Monitoring Progression/Regression) – Insights from MESA, ACCURACY, and Other Studies

Matthew Budoff, M.D.

1:45 pm – 2:15 pm
Ankle Brachial Index / PAD (Peripheral Arterial Disease) Screening
Marge Lovell, R.N., C.C.R.C., C.V.N., B.Ed. and Kirk Geter, D.P.M.

Harvey Hecht, M.D.

Paolo Raggi, M.D.

Dan Berman, M.D.

Sanjay Kaul, M.D., M.P.H.

H. Robert Superko, M.D.

Steven Rosenberg, Ph.D.

3:45 pm – 4:30 pm
Emergence of New (and Expensive?) Therapies and Their Potential Effect on the SHAPE Guidelines; Discussion Includes both Focal/Local (Interventional) Therapies and Systemic (Drug) Therapies
Raimund Erbel, M.D.

4:30 pm – 5:00 pm
Emergence of Polypills (Unconditional Therapy) and Their Effect on the SHAPE Guidelines
Erling Falk, M.D., Ph.D.

Raimund Erbel, M.D. – Germany

Erling Falk, M.D., Ph.D.

Kirk Geter, D.P.M.

Sanjay Kaul, M.D., M.P.H.

Jim Ehrlich, M.D. – United States

Marge Lovell, R.N., C.C.R.C., C.V.N., B.Ed. – Canada

10:30 am – 11:00 am

Reimbursement for Cardiovascular Screening of the Asymptomatic Population, What do Payers Say and Do?
For Coronary Calcium Screening – Matthew Budoff, M.D.

2:15 pm – 2:45 pm

Pros and Cons of Screening based on Systematic Biomarkers of Inflammation CRP (and LP-PLA2)
Michael H. Davidson, M.D.

2:45 pm – 3:30 pm

Update on Other Non-invasive, Non-imaging Modalities for Early Detection of Asymptomatic Atherosclerosis and Monitoring Response to Therapy (Vascular / Endothelial Function / Arterial Stiffness, and Genetic Tests)
Iftikhar J. Kullo, M.D.

Sunday, August 1, 2010

8:00 am – 8:45 am
Barriers to Adoption of Cardiovascular Screening by Primary Care Practitioners
George P. Rodgers, M.D. – United States

8:45 am – 9:15 am

Legislative Initiatives for Cardiovascular Screening (Texas, U.K., Denmark, other)

Morteza Naghavi, M.D.

9:15 am – 10:15 am

Training, Certification, and Accreditation Issues – Uniformity of testing (CIMT and ABI); Certifying Bodies; Certification of Labs, Technicians, Nurses, Physician Assistants and Physicians
Tasneem Naqvi, M.D.

For Carotid IMT Screening – Tasneem Naqvi, M.D.

12:00 pm – 12:45 pm
Discuss the Long Anticipated NIH Study Comparing SHAPE with Status Quo
Matthew Budoff, M.D.